Bolt Biotherapeutics, Inc.

BOLT - CIK 0001641281

Market cap-

Rank-

SEC filings278

BOLT balance sheet (annual)

The table below shows Bolt Biotherapeutics, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Cash & equivalents	$11.70M	$7.21M	$10.81M	$9.24M	$27.38M
Short-term investments	$15.80M	$40.12M	$91.38M	$159.64M	$158.84M
Receivables	-	-	-	-	-
Inventory	-	-	-	-	-
Total current assets	$30.26M	$50.81M	$105.71M	$172.75M	$189.16M

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.